VTCQ usually doesn't trade in lockstep with the broader markets. More often than not - it usually trades opposite. The large gap down in pps is probably because of the failed rumor, the absurdly low $12k of revenues last quarter, and people finding out that VTCQ USA gets 0% off international sales of VitaStiks. The VitaStik failure domestically was confirmed by the piddly $12k last quarter, hence, the "relaunch"
If the relaunch only consists of changing the name from VitaStik to VitaCig - everyone needs to brace themselves for another failure.
News 
Market Data 
Discover 
AI
